GEM-240

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGEM-240
Drug Alias Nameantisense oligonucleotides (Hybridon)antisense oligonucleotides (Hybridon/Searle)antisense oligonucleotides (Idera/Searle)oligonucleotide (Idera/Searle)oligonucleotide (Idera/Searle) +[12] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionApoptosis modulatorsAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantationCardiovascular DiseasesArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAceragen IncG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationCardiovascular DiseasesArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A